Fujii Yoshio, Tsurumi Ken, Sato Masaaki, Takahashi Eizo, Okamoto Keinosuke
Institute of Pharmacognosy, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro, Tokushima, Tokushima 770-8514, Japan.
Infect Immun. 2008 Mar;76(3):1076-82. doi: 10.1128/IAI.01098-07. Epub 2007 Dec 17.
To clarify the mechanisms of diarrheal disease induced by Aeromonas sobria, we examined whether prostaglandin E2 (PGE2) was involved in the intestinal secretory action of A. sobria hemolysin by use of a mouse intestinal loop model. The amount of PGE2 in jejunal fluid and the fluid accumulation ratio were directly related to the dose of hemolysin. The increase over time in the level of PGE2 was similar to that of the accumulated fluid. In addition, hemolysin-induced fluid secretion and PGE2 synthesis were inhibited by the selective cyclooxygenase 2 (COX-2) inhibitor NS-398 but not the COX-1 inhibitor SC-560. Western blot analysis revealed that hemolysin increased the COX-2 protein levels but reduced the COX-1 protein levels in mouse intestinal mucosa in vivo. These results suggest that PGE2 functions as an important mediator of diarrhea caused by hemolysin and that PGE2 is produced primarily through a COX-2-dependent mechanism. Subsequently, we examined the relationship between PGE2, cyclic AMP (cAMP), and cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels in mouse intestinal mucosa exposed to hemolysin. Hemolysin increased the levels of cAMP in the intestinal mucosa. NS-398 inhibited the increase in cAMP production, but SC-560 did not. In addition, H-89, a cAMP-dependent protein kinase A (PKA) inhibitor, and glibenclamide, a CFTR inhibitor, inhibited fluid accumulation. Taken together, these results indicate that hemolysin activates PGE2 production via COX-2 and that PGE2 stimulates cAMP production. cAMP then activates PKA, which in turn stimulates CFTR Cl- channels and finally leads to fluid accumulation in the intestines.
为阐明温和气单胞菌引起腹泻病的机制,我们利用小鼠肠袢模型研究了前列腺素E2(PGE2)是否参与温和气单胞菌溶血素的肠道分泌作用。空肠液中PGE2的量和液体蓄积率与溶血素剂量直接相关。PGE2水平随时间的增加与蓄积液体的增加相似。此外,选择性环氧化酶2(COX-2)抑制剂NS-398可抑制溶血素诱导的液体分泌和PGE2合成,但COX-1抑制剂SC-560则无此作用。蛋白质印迹分析显示,溶血素可提高小鼠肠黏膜中COX-2蛋白水平,但降低COX-1蛋白水平。这些结果表明,PGE2是溶血素引起腹泻的重要介质,且PGE2主要通过COX-2依赖性机制产生。随后,我们研究了暴露于溶血素的小鼠肠黏膜中PGE2、环磷酸腺苷(cAMP)和囊性纤维化跨膜传导调节因子(CFTR)Cl-通道之间的关系。溶血素可提高肠黏膜中cAMP水平。NS-398可抑制cAMP生成的增加,但SC-560则无此作用。此外,cAMP依赖性蛋白激酶A(PKA)抑制剂H-89和CFTR抑制剂格列本脲可抑制液体蓄积。综上所述,这些结果表明,溶血素通过COX-2激活PGE2生成,PGE2刺激cAMP生成。cAMP随后激活PKA,PKA进而刺激CFTR Cl-通道,最终导致肠道液体蓄积。